NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...
NanoVax Herpes Simplex Virus Vaccine
NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. Read more...
NasoVAX Influenza Vaccine
NasoVAX is a recombinant intranasal vaccine that is RD-Ad5-based, being developed for both seasonal and pandemic use, possibly including COVID-19.Read more...
NEO-PV-01 Cancer Vaccine
NEO-PV-01 Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...
NeoVax Cancer Vaccine
NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...
Nirsevimab RSV Vaccine
Nirsevimab is a vaccine candidate that is a first-in-class single-dose immunization to provide protection for all infants entering their first RSV seasonRead more...
nOPV2 Polio Vaccine
nOPV2 Polio Vaccine candidate is derived from the live, infectious virus — but this time it has been ‘triple-locked’ using genetic engineering, to prevent it from becoming harmfulRead more...
Novavax Nuvaxovid COVID-19 Vaccine
Novavax's Nuvaxovid CovoVax COVID-19 vaccine (NVX-CoV2372, TAK-019) (SARS-CoV-2 rS [Recombinant, adjuvanted)) is a protein-based vaccine candidate engineered from the genetic sequence of the first strain of SARS-CoV-2.Read more...
